To translate our findings on macrophage activation and T-cell crosstalk induced by PSGL-1 blockade to an in vivo setting, we analyzed tumor growth and profiled tumor associated and peripheral immune cells in a patient-derived melanoma model (AV17.26) in humanized mice. The gene discussed is SELPLG; the disease is melanoma.